I agree that this site is using cookies. You can find further informations here.
X
Telli, Melinda L.
89  results:
Search for persons X
?
1

Tumor-infiltrating lymphocytes and breast cancer mortality ..:

Ransohoff, Julia D ; Miller, Iain ; Koo, Jocelyn...
JNCI Cancer Spectrum.  8 (2024)  2 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
2

Neoadjuvant talazoparib in patients with germline BRCA1/2 m..:

Telli, Melinda L. ; Litton, Jennifer K. ; Beck, J. Thaddeus...
Breast Cancer.  , 2024
Link: https://doi.org/10.1007/..
 
?
3

Antimicrobial exposure is associated with decreased surviva..:

Ransohoff, Julia D. ; Ritter, Victor ; Purington, Natasha...
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
4

Neoadjuvant Talazoparib in Patients With Germline BRCA1/2 M..:

Litton, Jennifer K ; Beck, J Thaddeus ; Jones, Jason M...
The Oncologist.  , 2023
Link: https://doi.org/10.1093/..
 
?
5

Generation of two induced pluripotent stem cell lines from ..:

Zhang, Mao ; Liu, Wenqiang ; Li, Audrey...
Stem Cell Research.  72 (2023)  - p. 103219 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Genomic analysis of advanced breast cancer tumors from tala..:

Turner, Nicholas C. ; Laird, A. Douglas ; Telli, Melinda L....
npj Breast Cancer.  9 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
7

Identifying homologous recombination deficiency in breast c..:

Lenz, Lauren ; Neff, Chris ; Solimeno, Cara...
Breast Cancer Research and Treatment.  202 (2023)  1 - p. 191-201 , 2023
Link: https://doi.org/10.1007/..
 
?
8

Generation and characterization of induced pluripotent stem..:

Zhang, Mao ; Venkateshappa, Ravichandra ; Li, Audrey...
Stem Cell Research.  73 (2023)  - p. 103246 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Response to trastuzumab deruxtecan in a patient with HER2-l..:

Testa, Stefano ; Dickerson, James C. ; Telli, Melinda
Current Problems in Cancer: Case Reports.  11 (2023)  - p. 100258 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Phase 1b study of berzosertib and cisplatin in patients wit..:

Telli, Melinda L. ; Tolaney, Sara M. ; Shapiro, Geoffrey I....
npj Breast Cancer.  8 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
11

Emerging strategies: PARP inhibitors in combination with im..:

Gupta, Tanya ; Vinayak, Shaveta ; Telli, Melinda
Breast Cancer Research and Treatment.  197 (2022)  1 - p. 51-56 , 2022
Link: https://doi.org/10.1007/..
 
?
12

A phase II study of talazoparib monotherapy in patients wit..:

Gruber, Joshua J. ; Afghahi, Anosheh ; Timms, Kirsten...
Nature Cancer.  3 (2022)  10 - p. 1181-1191 , 2022
Link: https://doi.org/10.1038/..
 
?
13

Glembatumumab vedotin for patients with metastatic, gpNMB o..:

Vahdat, Linda T. ; Schmid, Peter ; Forero-Torres, Andres...
npj Breast Cancer.  7 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
14

A Phase I Dose-Escalation and Expansion Study of Telaglenas..:

Harding, James J. ; Telli, Melinda ; Munster, Pamela...
Clinical Cancer Research.  27 (2021)  18 - p. 4994-5003 , 2021
Link: https://doi.org/10.1158/..
 
?
15

Neoadjuvant atezolizumab in combination with sequential nab..:

Mittendorf, Elizabeth A ; Zhang, Hong ; Barrios, Carlos H...
The Lancet.  396 (2020)  10257 - p. 1090-1100 , 2020
Link: https://doi.org/10.1016/..
 
1-15